A Novel Class of Highly Potent Irreversible Hepatitis C Virus NS5B Polymerase Inhibitors.
Chen, K.X., Lesburg, C.A., Vibulbhan, B., Yang, W., Chan, T.Y., Venkatraman, S., Velazquez, F., Zeng, Q., Bennett, F., Anilkumar, G.N., Duca, J., Jiang, Y., Pinto, P., Wang, L., Huang, Y., Selyutin, O., Gavalas, S., Pu, H., Agrawal, S., Feld, B., Huang, H.C., Li, C., Cheng, K.C., Shih, N.Y., Kozlowski, J.A., Rosenblum, S.B., Njoroge, F.G.(2012) J Med Chem 55: 2089-2101
- PubMed: 22247956 
- DOI: 10.1021/jm201322r
- Primary Citation of Related Structures:  
3TYQ - PubMed Abstract: 
Starting from indole-based C-3 pyridone HCV NS5B polymerase inhibitor 2, structure-activity relationship (SAR) investigations of the indole N-1 benzyl moiety were performed. This study led to the discovery of irreversible inhibitors with p-fluoro-sulfone- or p-fluoro-nitro-substituted N-1 benzyl groups which achieved breakthrough replicon assay potency (EC(50) = 1 nM) ...